Cytek investor
WebFeb 13, 2024 · An existing installed base of more than 7,000 instruments will be under the Cytek umbrella following the acquisition, expanding the company’s global commercial footprint. The decision to sell the FCI business unit to Cytek is in line with the strategic priorities communicated to investors during the Capital Market Day in December 2024. WebFeb 28, 2024 · Cytek will host a conference call to discuss the fourth quarter 2024 financial results on Tuesday, February 28, 2024, at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. A webcast of the conference call can be accessed at investors.cytekbio.com. About Cytek Biosciences, Inc.
Cytek investor
Did you know?
WebFeb 21, 2024 · Unfortunately, Cytek Biosciences Inc’s P/E ratio is not significant enough to use for stock price evaluation. We recommend investors evaluate other financial metrics to understand its overall valuation. Cytek Biosciences Inc Stock Price History. Cytek Biosciences Inc’s (CTKB) price is currently down 8.96% so far this month. WebFeb 7, 2024 · Therefore, investors should monitor Cytek’s website, LinkedIn page, and Twitter account in addition to following its SEC filings, news releases, public conference calls and webcasts. Investor ...
WebInvestors Resources. expand_more expand_less. ... All content contained within this website, including pictures, cannot be used without express authorization from Cytek ... WebMay 18, 2024 · See CyTek funding rounds, investors, investments, exits and more. Evaluate their financials based on CyTek's post-money valuation and revenue. CyTek …
WebCytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by ... WebDescription. Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core …
WebFeb 28, 2024 · Cytek Biosciences, Inc. is a leading cell analysis solutions company advancing the next generation of cell analysis tools by delivering high-resolution, high … The Investor Relations website contains information about Cytek Biosciences's … Cytek Biosciences to Report Fourth Quarter and Full Year 2024 Financial Results on … Mar 24, 2024: 144: Filed by "insiders" prior intended sale of restricted stock. Non … Cytek® Biosciences to Acquire Flow Cytometry and Imaging Business from … Wenbin Jiang, Ph.D. has served as Cytek’s Chief Executive Officer and a member of … The Investor Relations website contains information about Cytek Biosciences's … Cytek was incorporated in Delaware in 2014 under the name Cytoville, Inc. In August …
chiming wall clock with pendulumWebMar 31, 2024 · Cytek Biosciences now expects full year 2024 revenue to be closer to the high end of the range of $160 million to $168 million. Cytek will host a conference call to discuss the first quarter 2024 financial results on Wednesday, May 11, 2024, at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time. A webcast of the conference call can be accessed … graduated gold chain necklaceWebNov 21, 2024 · Therefore, investors should monitor Cytek’s website, LinkedIn page, and Twitter account in addition to following its SEC filings, news releases, public conference calls and webcasts. graduated gold filterWebFeb 13, 2024 · A webcast of the conference call can be accessed at investors.cytekbio.com. About DiaSorin Headquartered in Italy and listed at the Italian … chiming wrist watchWebFeb 13, 2024 · Investors 9 Funding Cytek Biosciences has raised a total of $144.3M in funding over 5 rounds. Their latest funding was raised on … chimin health managementWebApr 11, 2024 · Cytek Biosciences Inc’s price is currently up 3.92% so far this month. During the month of April, Cytek Biosciences Inc’s stock price has reached a high of $9.66 and a low of $8.47. Over the last year, Cytek Biosciences Inc has hit prices as high as $16.05 and as low as $7.38. Year to date, Cytek Biosciences Inc’s stock is down 41.48%. chiming wind up wall clocksWebFind the latest Cytokinetics, Incorporated (CYTK) stock quote, history, news and other vital information to help you with your stock trading and investing. graduated golf tees